Procaps Group SA News - PROC

Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors

Experienced Pharma Professional Brings Wealth of International Industry and Governance Experience to Board Procaps Group (NASDAQ: PROC...

Procaps Group to Participate at CPHI Barcelona 2023

Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will...

Procaps Group to Host Webinar on Colombian Pharma Market

The Webinar will occur on Tuesday, October 10, 2023 at 10:00 a.m. Eastern Time Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated...

Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October

Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company...

Procaps Group Announces the Expansion of its Oncology Portfolio

The Agreement Substantially Increases Procaps' Participation in the Oncology Market in the LatAm Region Procaps Group, S.A. (NASDAQ: PROC...

Procaps Group Reports Second Quarter 2023 Results

Net Revenues Increased 7% in 1H23 Year-over-Year, on a Constant Currency Basis, Signaling Positive Performance of Rx Products Procaps Group, S.A...

Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday

Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical services company, announced that it will...

Procaps Group Publishes White Paper on Innovative Gummy Technology

Introduces New High Temperature Gummy Technology Platform that Solves Formulation and Distribution Challenges Procaps Group, S.A. (NASDAQ: PROC...

Procaps Group Reports First Quarter 2023 Results

MIAMI and BARRANQUILLA, Colombia, June 05, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC...

Procaps Group Reports Fourth Quarter and Full Year 2022 Results

Constant Currency Net Revenues Increased 7% Year-over-Year in 2022, With Strong Demand of RX and Softgel Portfolios, Offset by Clinical Specialty...

Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing

MIAMI and BARRANQUILLA, Colombia, May 01, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC...

Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance

Reports Preliminary Financial Estimates for Net Revenue and Adjusted EBITDA for Full Year 2022 Realigns Board...

Procaps Announces Key Changes to the Board of Directors

MIAMI and BARRANQUILLA, Colombia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”...

Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar

MIAMI and BARRANQUILLA, Colombia, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC...

Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference

MIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Procaps Group SA (PROC)

Professional-Grade Tools, for Individual Investors.

PROC News

Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors

Procaps Group to Participate at CPHI Barcelona 2023

Procaps Group to Host Webinar on Colombian Pharma Market

Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October

Procaps Group Announces the Expansion of its Oncology Portfolio

Procaps Group Reports Second Quarter 2023 Results

Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday

Procaps Group Publishes White Paper on Innovative Gummy Technology

Procaps Group Reports First Quarter 2023 Results

Procaps Group Reports Fourth Quarter and Full Year 2022 Results

Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing

Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance

Procaps Announces Key Changes to the Board of Directors

Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar

Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference

PROC Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Procaps Group SA (PROC) News

Procaps Group SA (PROC)

Professional-Grade Tools, for Individual Investors.

PROC News

Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors

Procaps Group to Participate at CPHI Barcelona 2023

Procaps Group to Host Webinar on Colombian Pharma Market

Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October

Procaps Group Announces the Expansion of its Oncology Portfolio

Procaps Group Reports Second Quarter 2023 Results

Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday

Procaps Group Publishes White Paper on Innovative Gummy Technology

Procaps Group Reports First Quarter 2023 Results

Procaps Group Reports Fourth Quarter and Full Year 2022 Results

Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing

Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance

Procaps Announces Key Changes to the Board of Directors

Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar

Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference

PROC Discussion

Your Recent History